BDBM742449 5-[[2-[5- fluoro-6-(2,2,2- trifluoroethyl) quinazolin-4-yl]-2,7- diazaspiro[3.5] nonan-7- yl]methyl]-4-methyl-1- [(2S)-2-(4-methyl- sulfonylpiperazin-1- yl)propyl]indole- 2-carbonitrile::US20250163061, Compound 57

SMILES Cc1c(CN2CCC3(CC2)CN(c2ncnc4ccc(CC(F)(F)F)c(F)c24)C3)ccc2c1cc(C#N)n2C[C@H](C)N1CCN(S(C)(=O)=O)CC1

InChI Key InChIKey=VMACPCYTHIYPFU-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 742449   

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742449(5-[[2-[5- fluoro-6-(2,2,2- trifluoroethyl) quinazo...)
Affinity DataEC50: <75nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/19/2025
Entry Details
Go to US Patent